Study to Develop a Minimally-Invasive Seizure Gauge

Overview

About this study

The purpose of this study is to develop and validate all components of a minimally-invasive seizure detection and forecasting system.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients with epilepsy-scalp EEG or invasive EEG monitoring for clinical care.
Patients with an implanted device capable of monitoring brain activity and identifying seizures (e.g., NeuroPace RNS, Medtronic PC+S, Medtronic RC+S). Patients with epilepsy.
Patients 3 years of age and older.
Healthy control subjects, age 18 and over.

Exclusion Criteria:

Cognitive or psychiatric condition rendering patient unable to manage and recharge smart watch and tablet computer devices.
open or healing wounds near monitoring sites (infection risk).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Benjamin Brinkmann, Ph.D.	Closed for enrollment	Contact information: Sherry Klingerman CCRP (507)284-0451 klingerman.sherry@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Benjamin Brinkmann, Ph.D.

Closed for enrollment

Contact information:

Sherry Klingerman CCRP

(507)284-0451

klingerman.sherry@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials